Breast cancerBrain metastasesHER2WBRTStereotactic radiosurgeryCheckpoint inhibitorsTargeted agentsTrastuzumabLapatinibNeratinibIn the past, the standard of care for treatment of BM was whole brain radiation therapy (WBRT), stereotactic radiosurgery (SRS), and surgery. There has been a greater role for ...
ai asked how i could print this document 我问怎么我可能打印本文 [translate] aCan you buy them in China? 您能否买他们在中国? [translate] aCurrent treatment options in triple negative breast cancer. 当前治疗选择在三倍消极乳腺癌。 [translate] ...
Pilch YN.Breast cancer treatment - current status.PostgradMed.1983.126-129Pilch YN. Breast cancer treatment - current status [ J ]. PostgradMed ,1983,74(3):126-129.Breast cancer treatment-current status. Pilch YN. Postgraduate Medical Journal . 1983...
Pilch YN.Breast cancer treatment - current status.PostgradMed.1983.126-129Pilch YN. Breast cancer treatment - current status [ J ]. PostgradMed ,1983,74(3):126-129.Breast cancer treatment-current status. Pilch YN. Postgraduate Medical Journal . 1983...
the growing interest in BC epigenetics, suggesting a potential shift from a one-size-fits-all approach to precision medicine, and emphasizes the necessity for robust evidence on their efficacy and safety to support continuous development and approval, addressing the unmet needs in BC treatment. ...
Breast cancer metastases to the central nervous system (CNS) has devastating consequences for the individual. As treatment options for metastatic breast cancer expand and as quality of life and overall survival improve, researchers are targeting potential treatments for this sanctuary site. Attention is...
Only recently has the realization that breast cancer disseminates at an early stage led to an emphasis on breast-conserving surgery combined with systemic treatment; currently used modalities of these therapies are reviewed, including adjuvant treatment and chemotherapy, together with indications for ...
Breast cancer: current issues in diagnosis and treatment. The diagnosis and treatment of breast cancer in Australia has changed in response to new technologies and cultural influences which have emphasized the imp... J Crowley - 《Australian & New Zealand Journal of Surgery》 被引量: 69发表: 19...
Human epidermal growth factor receptor 2 (HER2) has been found to be an important prognostic and predictive marker of treatment response in women with breast cancer in the adjuvant setting and advanced disease. The HER2 gene is amplified and the HER2 protein is overexpressed in ~20% to 25% of...
Treatment of triple negative breast cancer (TNBC): current options and future perspectives De Laurentiis M; Cianniello D; Caputo R;.Treatment of triple negative breast cancer ( TNBC ) : current options and future perspectives.Cancer Treatment ... M.,De,Laurentiis,... - 《Cancer Treatment ...